Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal Neurocrine will acquire approved drug for rare disease that leaves people with insatiable hunger

https://www.statnews.com/2026/04/06/neurocrine-biosciences-soleno-therapeutics-acquisition-prader-willi-vykat/ By Allison DeAngelisApril 6, 2026 Biotech Startups and Venture Capital Reporter